(Q46707118)

24 December 2017

title

Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey (English)

1 reference

24 December 2017

Mycobacterium tuberculosis

main subject

0 references

1 reference

1 reference

Senol G

1

1 reference

24 December 2017

Erbaycu A

series ordinal

2

1 reference

24 December 2017

Ozsöz A

series ordinal

3

1 reference

24 December 2017

publication date

1 August 2005

1 reference

24 December 2017

published in

Journal of Chemotherapy

1 reference

24 December 2017

volume

17

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

380-384

1 reference

24 December 2017

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Antimicrobial activity of rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Qualitative and quantitative drug-susceptibility tests in mycobacteriology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Risk factors for rifampin mono-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

Use of rifabutin in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.380

10.1179/JOC.2005.17.4.380

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017